病例报告：一名患有难治性系统性肥大细胞增多症合并AML1::ETO+急性髓系白血病的儿科患者对吉妥珠单抗-奥佐米星迅速产生反应。
Case Report: Rapid response to gemtuzumab-ozogamicin in a pediatric patient with refractory systemic mastocytosis with AML1::ETO+ acute myeloid leukemia.
作者信息
Xue Song, Chen Man, Sun Hui-Peng, Wang Tong, Zhang Li-Na, Cao Xing-Yu
机构信息
Department of Bone Marrow Transplant, Beijing Lu Daopei Hospital, Beijing, China.
Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China.
出版信息
Front Immunol. 2025 Apr 9;16:1566805. doi: 10.3389/fimmu.2025.1566805. eCollection 2025.
Abstract
This article describes a 6-year-old patient diagnosed with "systemic mastocytosis with AML1::ETO+ AML", he experience refractory disease during the course of treatment and salvage treatment was ineffective. The patient was administered gemtuzumab-ozogamicin therapy, resulting in rapid remission.
摘要
本文描述了一名6岁患者，被诊断为“伴有AML1::ETO+急性髓系白血病的系统性肥大细胞增多症”，他在治疗过程中出现难治性疾病，挽救治疗无效。该患者接受了吉妥珠单抗-奥唑米星治疗，迅速获得缓解。
Zotero 插件